An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of cells commonly termed "cancer stem cells" that has been proposed to be a strong driving force of tumorigenesis and a key mechanism of therapeutic resistance. Recent advances in epigenomics have illuminated key mechanisms by which epigenetic regulation contribute to cancer progression. In this review, we present a discussion of how deregulation of various epigenetic pathways can contribute to cancer initiation and tumorigenesis, particularly with respect to maintenance and survival of cancer stem cells. This information, together with several promising clinical and preclinical trials of epigenetic modulating drugs, offer new possibilities for targeting cancer stem cells as well as improving cancer therapy overall.
Keywords:
Cancer stem cells; DNA methylation; Epigenetics; Histone methylation; Histone methyltransferase; Signaling pathway.
Regulation of key cancer stem cell signaling pathways by epigenetic mechanisms. Wnt/β-catenin signaling…
Fig. 1
Regulation of key cancer stem cell signaling pathways by epigenetic mechanisms. Wnt/β-catenin signaling can be enhanced by decreased expression of the DKK1 inhibitor through promoter hypermethylation and increased H3K27me3 and decreased H3K16 acetylation marks. Notch signaling target genes such as Hes1 and Hes5 can be activated by inhibition of H3K27 inhibitory methylation mark at their promoter region by STRAP. Hedgehog signaling pathway can be activated in CSCs epigenetically by Shh promoter hypomethylation and increase HDAC1 expression. Epigenetic deregulation of CSC-related signaling pathways allows cancer cells to acquire self-renewal ability and drug resistance properties
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. doi: 10.1038/35102167.
-
DOI
-
PubMed
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–737. doi: 10.1038/nm0797-730.
-
DOI
-
PubMed
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–648. doi: 10.1038/367645a0.
-
DOI
-
PubMed
Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111–115. doi: 10.1038/nature05384.
-
DOI
-
PubMed